Renal Cell Carcinoma: Focus on Safety and Efficacy of Temsirolimus

Metastatic renal cell carcinoma has harboured a poor prognosis for decades with immunotherapy being the only available therapy with high toxicity and modest effect. Dependance of renal cell carcinoma oncogenesis on the mTOR pathway has led to clinical development of temsirolimus in this setting. Thi...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Hadoux, Julien, Vignot, Stephane, De La Motte Rouge, Thibault
Format: Artigo
Jezik:Inglês
Izdano: Libertas Academica 2010
Teme:
Review
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3018897/
https://ncbi.nlm.nih.gov/pubmed/21234295
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4137/CMO.S4482
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki